Expression of soluble PD-1 in the sera of patients with recurrent genital herpes and its immunologic significance
	    		
		   		
		   			 
		   		
	    	
    	 
    	10.3760/cma.j.issn.0412-4030.2011.05.024
   		
        
        	
        		- VernacularTitle:复发性生殖器疱疹患者血清可溶性PD-1的表达和免疫学意义
- Author:
	        		
		        		
		        		
			        		Jian WU
			        		
			        		;
		        		
		        		
		        		
			        		Guoquan JIA
			        		
			        		;
		        		
		        		
		        		
			        		Ruibin WU
			        		
			        		;
		        		
		        		
		        		
			        		Ping XU
			        		
			        		;
		        		
		        		
		        		
			        		Yongjing CHEN
			        		
			        		;
		        		
		        		
		        		
			        		Minzhi WU
			        		
			        		;
		        		
		        		
		        		
			        		Yicheng ZHANG
			        		
			        		;
		        		
		        		
		        		
			        		Xueguang ZHANG
			        		
			        		
		        		
		        		
		        		
 
			        		
			        		
		        		 
- Publication Type:Journal Article
- From:
	            		
	            			Chinese Journal of Dermatology
	            		
	            		 2011;44(5):360-361
	            	
            	
- CountryChina
- Language:Chinese
- 
		        	Abstract:
			       	
			       		
				        
				        	Objective To determine the concentration of soluble PD-1 (sPD-1) in the sera of patients with recurrent genital herpes (RCH), and to explore the significance of abnormal expression of sPD-1 in RCH. Methods Serum samples were obtained from 88 healthy blood donors, 74 patients with RCH including 34 cases of outbreak-stage RCH and 40 cases of stable-stage RCH. The serum level of sPD-1 was measured by monoclonal antibody labeling and enzyme linked immunosorbent assay (ELISA). Results A significant difference was observed in the serum level of sPD-1 between the patients with RGH and the blood donors (33.06 ± 17.5 μg/L vs. 53.07 ± 26.3μg/L, P < 0.01) and between the patients with outbreak-stage RGH and those with stable-stage RGH (27.47 ± 12.9 μg/L vs. 37.71 ± 19.6 μg/L, P< 0.01). Conclusions There is a low expression of sPD-1 in patients with RGH, which may be one of the mechanisms underlying the escape of HSV- Ⅱ from immunologic surveillance and development of immunological tolerance.